Health Trials

Relapsed or Refractory EBV-associated Hematological Malignancies

1

Review clinical trials related to Relapsed or Refractory EBV-associated Hematological Malignancies. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

The main purpse of this study is to evaluate the safety and tolerability of KSD-101 in the treatment of relapsed or refractory EBV-associated hematological malignancies,to preliminarily explore the clinical efficacy ,evaluate the immune response to KSD-101 for the treatment in Patients with EBV-associated hematological diseases and the improvement in subjects' quality of life (QOL) after KSD-101 treatment.

Participants needed: 55
Trial details
Phase: Phase 1Age: 2-70Biological sex: AllType: InterventionalSponsor: Kousai Bio Co., Ltd.Updated: Apr 16, 2026Locations: 2
Eligibility criteria

Subjects and/or their legal guardians agree to participate and sign the ICF. [+13]

Received chemotherapy or immunosuppressive therapy within 4 weeks prior to leuka... [+18]

Read more